• Home
  • Assessment of Patients Receiving Short-Interval Botulinum Toxin Chemodenervation Treatment for Laryngeal Dystonia and Essential Tremor of the Vocal Tract.

Assessment of Patients Receiving Short-Interval Botulinum Toxin Chemodenervation Treatment for Laryngeal Dystonia and Essential Tremor of the Vocal Tract.

Author List
Lagos-Villaseca A, Bhatt NK, Abdolhosseini P, Quinonez L, Paoletti MF, Gochman G, Johns MM, Rosen CA, Kao TC, Meyer TK
Publication
JAMA otolaryngology-- head & neck surgery
Publication ID (Profile URL)
https://researcherprofiles.org/profile/410622391
Publication Year
2023
PubMed ID
37227721
Publication Title
Lagos-Villaseca A, Bhatt NK, Abdolhosseini P, Quinonez L, Paoletti MF, Gochman G, Johns MM, Rosen CA, Kao TC, Meyer TK. Assessment of Patients Receiving Short-Interval Botulinum Toxin Chemodenervation Treatment for Laryngeal Dystonia and Essential Tremor of the Vocal Tract. JAMA Otolaryngol Head Neck Surg. 2023 07 01; 149(7):615-620.